| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 52.659 | 49.610 | 59.550 | 66.008 | 54.529 | 54.212 | 97.958 | 94.211 | 91.223 | 171.061 |
| Total Income - EUR | 52.692 | 49.611 | 59.590 | 66.009 | 54.531 | 54.212 | 97.961 | 94.214 | 91.225 | 171.061 |
| Total Expenses - EUR | 52.350 | 49.110 | 57.401 | 64.167 | 56.826 | 53.311 | 91.676 | 88.365 | 90.054 | 160.768 |
| Gross Profit/Loss - EUR | 342 | 501 | 2.189 | 1.841 | -2.295 | 901 | 6.285 | 5.849 | 1.171 | 10.293 |
| Net Profit/Loss - EUR | -1.240 | 4 | 1.592 | 1.181 | -2.798 | 608 | 5.577 | 5.095 | 512 | 8.652 |
| Employees | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Noni Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 642 | 477 | 312 |
| Current Assets | 10.750 | 8.308 | 12.748 | 16.643 | 9.406 | 11.834 | 38.726 | 13.515 | 24.745 | 56.958 |
| Inventories | 4.782 | 4.022 | 3.620 | 3.647 | 3.768 | 3.966 | 15.214 | 5.744 | 8.235 | 15.746 |
| Receivables | 5.480 | 3.639 | 9.074 | 12.472 | 5.571 | 7.664 | 18.789 | 5.346 | 14.406 | 33.185 |
| Cash | 488 | 647 | 55 | 524 | 67 | 203 | 4.723 | 2.424 | 2.103 | 8.028 |
| Shareholders Funds | -6.489 | -6.419 | -4.719 | -3.451 | -6.181 | -5.456 | 241 | 5.337 | 5.833 | 8.701 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 17.253 | 14.727 | 17.519 | 20.144 | 15.644 | 17.333 | 38.596 | 8.931 | 19.541 | 48.737 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Noni Pharm Srl